Focused radiation after surgery for certain meningiomas
Part of Brain & nervous system, Cancer clinical trials.
This study tests a type of focused radiation therapy (called stereotactic radiosurgery) given after surgery for certain meningiomas. The goal is to see if this treatment helps prevent the tumor from coming back, and to check its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of a grade 2 meningioma (newly diagnosed) or a recurring grade 1 meningioma.
- You must have had a complete surgical removal of the meningioma (as deemed by your neurosurgeon).
- You must not have had radiation therapy to the brain that overlaps with the area to be treated in this study.
- You must not be pregnant (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
This study compares different radiation methods for treating a slow-growing, non-cancerous brain tumor at the base of the skull. It aims to see which approach best protects memory and thinking abilities.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This trial compares two approaches for people who have had surgery to remove a meningioma, a usually non-cancerous brain tumor. Depending on the tumor's risk level, participants either receive radiation therapy or are observed without additional treatment, to see which approach provides better control.
This trial studies whether radiation given after complete surgery can reduce regrowth of atypical (grade II) meningioma in certain people. It is mainly for tumors that did not involve the brain’s venous sinus and for patients who can safely have follow-up brain MRI scans.
This trial studies whether people with a grade II meningioma that has been completely removed by surgery should be monitored only or treated with radiation. It may help reduce the risk of the tumor coming back while balancing radiation side effects.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.